This global biotech stock could soar 398% in the next year, Morgan Stanley says
The company develops regenerative cell medicines for issues such as strokes and traumatic brain injuries.
Source link
- America’s housing dream is broken | CNN Business
- EV-maker Arrival gets delisting warning from Nasdaq
